Dmitry Balashov

2.1k total citations
81 papers, 749 citations indexed

About

Dmitry Balashov is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Dmitry Balashov has authored 81 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 35 papers in Immunology and 20 papers in Oncology. Recurrent topics in Dmitry Balashov's work include Hematopoietic Stem Cell Transplantation (44 papers), Immunodeficiency and Autoimmune Disorders (20 papers) and Acute Lymphoblastic Leukemia research (13 papers). Dmitry Balashov is often cited by papers focused on Hematopoietic Stem Cell Transplantation (44 papers), Immunodeficiency and Autoimmune Disorders (20 papers) and Acute Lymphoblastic Leukemia research (13 papers). Dmitry Balashov collaborates with scholars based in Russia, United Kingdom and United States. Dmitry Balashov's co-authors include Michael Maschan, Галина Новичкова, Alexandra Laberko, Alexei Maschan, Pavel Trakhtman, Elena Kurnikova, Alexey Maschan, Elena Boyakova, Anna Shcherbina and Anna Shcherbina and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Dmitry Balashov

57 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dmitry Balashov Russia	16	493	374	176	101	99	81	749
Alexei Maschan Russia	12	405 0.8×	225 0.6×	151 0.9×	66 0.7×	115 1.2×	31	567
Галина Новичкова Russia	12	332 0.7×	249 0.7×	121 0.7×	74 0.7×	89 0.9×	56	511
Jason Butler Australia	12	595 1.2×	330 0.9×	210 1.2×	99 1.0×	104 1.1×	43	900
Mary Sartor Australia	14	348 0.7×	262 0.7×	184 1.0×	241 2.4×	137 1.4×	36	737
Makito Tanaka Japan	15	244 0.5×	202 0.5×	166 0.9×	89 0.9×	56 0.6×	44	588
Mahasweta Gooptu United States	16	432 0.9×	192 0.5×	201 1.1×	82 0.8×	103 1.0×	66	683
Kellie Sprague United States	14	540 1.1×	250 0.7×	284 1.6×	217 2.1×	72 0.7×	30	903
Lujia Dong China	10	428 0.9×	239 0.6×	340 1.9×	125 1.2×	121 1.2×	34	748
Carmen Martín Spain	19	646 1.3×	252 0.7×	246 1.4×	153 1.5×	173 1.7×	47	916
Stéphanie Nguyen France	17	457 0.9×	347 0.9×	214 1.2×	60 0.6×	144 1.5×	49	791

Countries citing papers authored by Dmitry Balashov

Since Specialization

Citations

This map shows the geographic impact of Dmitry Balashov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Balashov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Balashov more than expected).

Fields of papers citing papers by Dmitry Balashov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry Balashov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Balashov. The network helps show where Dmitry Balashov may publish in the future.

Co-authorship network of co-authors of Dmitry Balashov

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry Balashov. A scholar is included among the top collaborators of Dmitry Balashov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry Balashov. Dmitry Balashov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nademi, Zohreh, Alexandra Laberko, Dmitry Balashov, et al.. (2025). Outcomes of Hematopoietic Stem Cell Transplantation in 5 Patients with Autosomal Recessive RIPK1-Deficiency. Journal of Clinical Immunology. 45(1). 65–65. 3 indexed citations

Laberko, Alexandra, et al.. (2025). Risk Factors for Hematopoietic Stem Cell Transplantation in Inborn Errors of Immunity. Transplantation and Cellular Therapy. 32(2). 197.e1–197.e10.

Pershin, Dmitry, et al.. (2024). Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children. Transplantation and Cellular Therapy. 30(4). 437.e1–437.e11. 1 indexed citations

Bazaev, A, et al.. (2024). A case of allogeneic hematopoietic stem cell transplantation in a patient with hyper-IgE syndrome. Pediatric Hematology/Oncology and Immunopathology. 23(2). 168–173. 1 indexed citations

Попов, А. М., et al.. (2022). Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 29(2). 127.e1–127.e9. 6 indexed citations

Kurnikova, Elena, et al.. (2022). The use of adoptive cell therapy for the treatment of SARS-CoV-2 in a patient after allogeneic hematopoietic stem cell transplantation. Pediatric Hematology/Oncology and Immunopathology. 21(2). 112–117.

Balashov, Dmitry, et al.. (2021). Treosulfan-based conditioning for hematopoietic stem cell transplantation in patients with Diamond–Blackfan anemia. Pediatric Hematology/Oncology and Immunopathology. 20(1). 40–45.

Shekhovtsova, Zhanna, et al.. (2021). The safety and effctiveness of donor memory T lymphocyte infusions after hematopoietic stem cell transplantation with ab T cell depletion platform in children with acute leukemia. Pediatric Hematology/Oncology and Immunopathology. 20(2). 12–28.

Balashov, Dmitry, Elena Kurnikova, Dmitry Pershin, et al.. (2021). Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell–Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia. Transplantation and Cellular Therapy. 27(4). 330.e1–330.e9. 12 indexed citations

10.

Laberko, Alexandra, et al.. (2021). Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency. Transplantation and Cellular Therapy. 28(3). 172.e1–172.e4. 1 indexed citations

11.

Balashov, Dmitry, Alexandra Laberko, K. A. Voronin, et al.. (2020). EFFICACY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM AN ALTERNATIVE DONOR ON THE PLATFORM OF TRANSPLANT CELL MODELING TECHNOLOGY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES. PEDIATRIA Journal named after G N SPERANSKY. 99(2). 43–51. 2 indexed citations

12.

Zvyagin, Ivan V., Dmitry Balashov, Ekaterina A. Komech, et al.. (2020). T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after αβ T cell-depleted hematopoietic stem cell transplantation. Bone Marrow Transplantation. 56(4). 900–908. 10 indexed citations

13.

Trakhtman, Pavel, et al.. (2019). The pathogen‐reduced red blood cell suspension: single centre study of clinical safety and efficacy in children with oncological and haematological diseases. Vox Sanguinis. 114(3). 223–231. 14 indexed citations

14.

Balashov, Dmitry, Alexandra Laberko, Anna Shcherbina, et al.. (2018). A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ+ and CD19+ Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome. Biology of Blood and Marrow Transplantation. 24(7). 1432–1440. 20 indexed citations

15.

Balashov, Dmitry, et al.. (2017). Osteopenia and osteoporosis after allogeneic hematopoietic stem cell transplantation, features of bone mineral turnover pathology in children. Pediatric Hematology/Oncology and Immunopathology. 16(4). 98–106. 1 indexed citations

16.

Deripapa, Elena, Dmitry Balashov, Yulia Rodina, et al.. (2017). Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT). Frontiers in Immunology. 8. 807–807. 25 indexed citations

17.

Киргизов, К. И., Dmitry Balashov, Pavel Trakhtman, et al.. (2016). Hematopoietic stem cell transplantation in patients with Fanconi anemia: the experience of the Russian Children's Clinical Hospital and the Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology. Russian Journal of Pediatric Hematology and Oncology. 3(1). 23–34.

18.

Maschan, Alexey, Dmitry Balashov, Elena Kurnikova, et al.. (2015). Efficacy of plerixafor in children with malignant tumors failing to mobilize a sufficient number of hematopoietic progenitors with G-CSF. Bone Marrow Transplantation. 50(8). 1089–1091. 22 indexed citations

19.

Balashov, Dmitry, et al.. (2014). Value of bioimpedance analysis and anthropometry for complication prediction in children with malignant and non-malignant diseases after hematopoietic stem cells transplantation. SHILAP Revista de lepidopterología.

20.

Balashov, Dmitry & Pavel Trakhtman. (2014). Features of transfusion therapy in patients undergoing hematopoietic stem cell transplantation. Review of the literature. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact